Secuenciación del tratamiento en CPRC - page 20

OS PFS
Response
Rate
PSA50 No. pts Reff Author
8.5 mo 3.6 mo NR 12.5% 8 ASCO GU 2014 Tian Zhang
NR NA NR 36% 28 ASCO GU 2014 Heather H. Cheng
NR 43 days 0 17.3% 23 ASCO GU 2014 GS Sandhu
NR 4.9 mo NR 27% 26 ASCO GU 2014
Francisco Emilio
Vera-Badillo
10.6 mo 4.6 mo NR 22% 47 Eur Urology 2015 Arun A. Azad
NR 4.7 mo NR 33.3% 30 The Prostate 2014 Daniel L. Suzman
NR 2.8 mo NR 30% 33 ASCO GU 2014 Matthew R. Smith
8.5 mo 3.6 mo 0 11% 9
Clin Genitourinary
Cancer 2015
Tian Zhang
32.4 mo
Not
reached
59% 78% 1717
New Engl J of
Medicine 2014
Tomasz M. Beer
PREVAIL
prequimioterapia
ENZALUTAMIDA ABIRATERONA